HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD – Trademark Portfolio
Entity Type: 99
HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LITMIDE. The owner is based in HANGZHOU CITY.
ROOM 206244, 20TH FLOOR, YANDAFANG WENYUAN BUILDING, NO. 426 BINWEN ROAD, PUYAN STREET, BINJIANG DISTRICT
HANGZHOU CITY , CN
Showing of trademarks Trademarks
Trademark Classifications
HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD have?
HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD file in?
HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD's most well-known trademarks?
HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD's registered trademark portfolio includes well-known marks such as LITMIDE. These are among 1 currently registered trademark in the portfolio.
What is HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD's trademark registration success rate?
HANGZHOU HEPBURN BRAND OPERATION MANAGEMENT CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.